ID   SNU-228
AC   CVCL_5035
SY   SNU228
DR   KCLB; 00228
DR   Wikidata; Q54955149
RX   PubMed=10619961;
RX   PubMed=19956504;
RX   PubMed=27993170;
RX   PubMed=34560848;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00228
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
RX   PubMed=10619961; DOI=10.1046/j.1464-410x.2000.00247.x;
RA   Shin K.-H., Ku J.-L., Kim W.-H., Lee S.-E., Lee C., Kim S.-W.,
RA   Park J.-G.;
RT   "Establishment and characterization of seven human renal cell
RT   carcinoma cell lines.";
RL   BJU Int. 85:130-138(2000).
//
RX   PubMed=19956504; DOI=10.4143/crt.2005.37.1.1;
RA   Ku J.-L., Park J.-G.;
RT   "Biology of SNU cell lines.";
RL   Cancer Res. Treat. 37:1-19(2005).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//
RX   PubMed=34560848; DOI=10.1186/s12885-021-08784-7;
RA   Yu H., Kim D.-J., Choi H.-Y., Kim S.M., Rahaman M.I., Kim Y.-H.,
RA   Kim S.W.;
RT   "Prospective pharmacological methodology for establishing and
RT   evaluating anti-cancer drug resistant cell lines.";
RL   BMC Cancer 21:1049.1-1049.13(2021).
//